Gregg Scarlett Unloaded 84,374 Shares of Bloomin' Brands, Inc. (BLMN); RELX PLC (RELX) Covered By 5 Bulls

Bloomin’ Brands Inc EVP&Pres. Outback Steakhouse and an insider Gregg Scarlett recently made a sale of 84,374 company shares having a total value $2,006,414 at the average stock price of $23.8. The chances that the deal stays a secret are super little in view of the massive amount of money involved. Today, Gregg Scarlett owns 749 shares which are roughly 0.0008% of the company’s market cap.

Among 8 analysts covering Relx (NYSE:RELX), 5 have Buy rating, 0 Sell and 3 Hold. Therefore 63% are positive. Relx had 9 analyst reports since August 27, 2015 according to SRatingsIntel. The stock of RELX PLC (NYSE:RELX) has “Buy” rating given on Wednesday, January 10 by Goldman Sachs. The firm earned “Buy” rating on Friday, February 9 by Deutsche Bank. The rating was upgraded by Credit Suisse to “Outperform” on Tuesday, November 22. The firm has “Equal-Weight” rating by Barclays Capital given on Monday, February 12. Jefferies upgraded the shares of RELX in report on Tuesday, February 21 to “Buy” rating. The company was downgraded on Tuesday, May 3 by Goldman Sachs. The stock of RELX PLC (NYSE:RELX) earned “Neutral” rating by UBS on Monday, May 15. The firm earned “Hold” rating on Thursday, August 27 by Berenberg. Bank of America reinitiated the shares of RELX in report on Tuesday, October 25 with “Buy” rating. See RELX PLC (NYSE:RELX) latest ratings:

12/02/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Equal-Weight Downgrade
09/02/2018 Broker: Deutsche Bank Old Rating: Hold New Rating: Buy Upgrade
10/01/2018 Broker: Goldman Sachs Old Rating: Neutral New Rating: Buy Upgrade

Since December 15, 2017, it had 0 buys, and 3 insider sales for $8.07 million activity. Shares for $7.80M were sold by SMITH ELIZABETH A on Friday, December 15. HERLIHY DONAGH also sold $190,020 worth of Bloomin' Brands, Inc. (NASDAQ:BLMN) shares. On Friday, January 12 Schmidt David Peter sold $78,750 worth of Bloomin' Brands, Inc. (NASDAQ:BLMN) or 3,500 shares.

Among 16 analysts covering Bloomin’ Brands (NASDAQ:BLMN), 3 have Buy rating, 2 Sell and 11 Hold. Therefore 19% are positive. Bloomin’ Brands has $27 highest and $17.0 lowest target. $22.11’s average target is -4.24% below currents $23.09 stock price. Bloomin’ Brands had 36 analyst reports since September 11, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Friday, December 22 with “Hold”. As per Friday, February 23, the company rating was maintained by Barclays Capital. The firm earned “Overweight” rating on Wednesday, January 24 by Barclays Capital. On Friday, September 11 the stock rating was initiated by Guggenheim with “Neutral”. The stock of Bloomin' Brands, Inc. (NASDAQ:BLMN) earned “Buy” rating by Goldman Sachs on Thursday, November 19. Credit Suisse upgraded the stock to “Outperform” rating in Monday, April 11 report. The firm earned “Outperform” rating on Monday, November 6 by BMO Capital Markets. Barclays Capital maintained the stock with “Buy” rating in Tuesday, January 16 report. The firm has “Hold” rating by Bank of America given on Wednesday, November 22. The rating was downgraded by OTR Global to “Mixed” on Friday, October 30.

BloominÂ’ Brands, Inc., through its subsidiaries, owns and operates casual, upscale casual, and fine dining restaurants primarily in the United States and internationally. The company has market cap of $2.12 billion. The firm operates through two divisions, U.S. and International. It has a 22.86 P/E ratio. The Company’s restaurant portfolio has four concepts: Outback Steakhouse, a casual steakhouse restaurant; CarrabbaÂ’s Italian Grill, a casual Italian restaurant; Bonefish Grill, an upscale casual seafood restaurant; and FlemingÂ’s Prime Steakhouse & Wine Bar, a contemporary steakhouse.

Investors sentiment decreased to 0.82 in Q3 2017. Its down 0.05, from 0.87 in 2017Q2. It worsened, as 25 investors sold Bloomin' Brands, Inc. shares while 68 reduced holdings. 25 funds opened positions while 51 raised stakes. 85.71 million shares or 8.54% less from 93.71 million shares in 2017Q2 were reported. Qs Invsts Limited Company invested in 0.03% or 223,903 shares. Putnam Invests Limited Com owns 259,629 shares for 0.01% of their portfolio. The New York-based Art Ltd Liability Company has invested 0.04% in Bloomin' Brands, Inc. (NASDAQ:BLMN). Mackenzie Fincl Corp has 0% invested in Bloomin' Brands, Inc. (NASDAQ:BLMN). Ubs Asset Mgmt Americas holds 0% of its portfolio in Bloomin' Brands, Inc. (NASDAQ:BLMN) for 75,912 shares. Cap Fund Sa has invested 0.02% in Bloomin' Brands, Inc. (NASDAQ:BLMN). Teachers Retirement Sys Of The State Of Kentucky holds 0.01% of its portfolio in Bloomin' Brands, Inc. (NASDAQ:BLMN) for 55,145 shares. D E Shaw And reported 0.04% stake. Pnc Svcs Gru holds 28,404 shares or 0% of its portfolio. Moreover, Skylands Capital Lc has 0.46% invested in Bloomin' Brands, Inc. (NASDAQ:BLMN). Jacobs Levy Equity Mgmt owns 109,730 shares. Maplelane Limited Com holds 250,001 shares or 0.09% of its portfolio. Envestnet Asset Management has 9,118 shares. 67,319 were accumulated by Deprince Race Zollo. Granite Point Mngmt L P holds 0.17% or 45,900 shares.

The stock decreased 1.58% or $0.37 during the last trading session, reaching $23.09. About 879,090 shares traded. Bloomin' Brands, Inc. (NASDAQ:BLMN) has risen 8.82% since March 1, 2017 and is uptrending. It has underperformed by 7.88% the S&P500.

RELX PLC provides information and analytics for professional and business clients in North America, Europe, and internationally. The company has market cap of $40.24 billion. The companyÂ’s Scientific, Technical & Medical segment offers information, analytics, and tools that help clients make decisions. It has a 18.17 P/E ratio. This segment provides research, reference, and education content; and database and decision tools for scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, and allied health professionals and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive firms, and governments.